New radiation combo aims to tame prostate cancer with fewer side effects

NCT ID NCT01596816

Completed Disease control Sponsor: Centre Oscar Lambret Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new way to give radiation to men with intermediate-risk prostate cancer. After standard radiation to the prostate and nearby glands, a precise, high-dose boost was added to the tumor. The goal was to improve cancer control while keeping side effects on the bladder and rectum low. 76 men took part, and researchers tracked their urinary and rectal function over time.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer neoplasm prostate adenocarcinoma prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER

Contacts and locations

Show contact details

Locations

Centre Alexis Vautrin

Vandœuvre-lès-Nancy, 54500, France
Centre Georges François Leclerc

Dijon, 21079, France
Centre Hospitalier Lyon Sud

Pierre-Bénite, 69310, France
Centre Léon Bérard

Lyon, 69373, France
Centre Oscar LAMBRET

Lille, 59020, France
Centre Paul Papin

Angers, 49933, France
Val d'Aurelle-Paul Lamarque

Montpellier, 34298, France